Klaviyo
KVYO
$20.19
+2.96%
Klaviyo, Inc. is a software-as-a-service (SaaS) company that provides a marketing automation and customer data platform enabling businesses to send targeted messages across email, SMS, and push notifications, with machine learning and AI capabilities layered on top; its initial and dominant use case is marketing automation for eCommerce merchants. Klaviyo is best characterized as a high-growth, product-led platform challenger in the marketing technology space, differentiated by its deep native integration with eCommerce ecosystems (notably Shopify) and a unified data-plus-application architecture that lets merchants measure and predict campaign performance in one system. The current investor narrative centers on the tension between durable ~26% revenue growth and a still-thin profitability profile, with the stock having de-rated sharply through 2026 as the market questions whether AI-driven marketing tools commoditize Klaviyo's core email franchise or, conversely, whether its proprietary first-party commerce data becomes a durable AI moat. Recent quarterly results showed a return to a net loss in Q2 2026 alongside continued gross margin compression and heavy stock-based compensation, while management has been aggressively repurchasing shares — a signal of confidence that has not yet been validated by the share price.…
KVYO
Klaviyo
$20.19
Related headlines
Investment Opinion: Should I buy KVYO Today?
Rating: Hold with a constructive bias. The core thesis is that Klaviyo's 7.65x PS and 3.19x EV/Sales already discount substantial execution risk, while the 'strong_buy' consensus (mean 1.35) and $26.57 average target (+55.6% upside) suggest the sell-off has overshot — but the company must first prove the margin and profitability inflection that the 16.20x forward PE requires. The stock is a show-me story, not a momentum buy.
Supporting evidence is genuinely mixed but leans favorable on valuation. Revenue grew 26.43% YoY to $370.58M in Q2 2026 with consistent sequential gains, free cash flow is $244.4M TTM at an ~18.7% margin, and the balance sheet carries $833.4M cash against debt-to-equity of just 0.10 and a 4.27 current ratio. The PS of 7.65x is roughly a quarter of the 32.64x seen a year ago, and even the lowest analyst target ($19.00) sits above the current price. Against this, gross margin compression to 72.62%, a -2.39% net margin, and a PEG of 8.36 show the earnings power is not yet real.
The biggest risks that could invalidate the thesis are continued gross-margin erosion below 72%, a growth deceleration below 20%, and SBC remaining elevated enough to keep GAAP earnings negative. This Hold would upgrade to Buy if Q3 shows gross margin stabilizing above 73% and operating margin turning positive, or if the stock breaks decisively above the $20.00-$20.60 resistance on volume; it would downgrade to Sell if revenue growth falls below 20% or the stock breaks the $12.53 52-week low. Verdict: fairly valued to modestly undervalued relative to its own history, but not yet proven cheap relative to peers given the margin trajectory.
Sign up to view all
KVYO 12-Month Price Forecast
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Klaviyo's 12-month outlook, with a consensus price target around $26.24 and implied upside of +30.0% versus the current price.
Average Target
$26.24
0 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
—
covering this stock
Price Range
$19 - $36
Analyst target range
Coverage is robust, with 21 analysts covering Klaviyo and a consensus recommendation of "strong_buy" (mean rating of 1.35 on a 1–5 scale where 1 is a strong buy). The average target price is $26.57, which implies approximately +55.6% upside from the current $17.08 price — a strikingly bullish consensus relative to the stock's brutal price action. The consensus clearly leans bullish, and the recent institutional ratings flow supports this: in early August 2026, Citigroup, Canaccord Genuity, Stifel, TD Cowen, and BTIG all reiterated Buy ratings, while Piper Sandler, Barclays, Stephens, and KeyBanc reiterated Overweight, with only Macquarie maintaining a Neutral stance. Notably, these are reiterations rather than upgrades, suggesting analysts are holding their bullish views through the drawdown rather than turning more constructive.
The target range spans $19.00 to $36.00 — a wide spread of nearly 90% between low and high, signaling high uncertainty and divergent views on the company's trajectory. The high target of $36.00 (roughly +111% upside) likely assumes multiple expansion back toward historical PS levels, sustained 25%+ growth, margin recovery as SBC normalizes, and successful AI-driven product differentiation. The low target of $19.00 (still +11% above the current price) prices in continued margin compression, competitive pressure from larger marketing platforms, and a slower growth trajectory — yet even the most bearish analyst sees modest upside, which is a notable signal that the sell-off may have overshot. The wide spread and the fact that even the low target sits above the current price suggest analysts collectively view the current valuation as dislocated, though the persistent reiteration-without-upgrade pattern and the stock's failure to respond indicate the market is waiting for tangible fundamental proof — likely a return to GAAP profitability and reaccelerating growth — before closing the gap to consensus targets.
Drowning in data?
Find the real signal!
Bulls vs Bears: KVYO Investment Factors
The bear case currently has stronger evidence in the price action and reported financials: gross margin is compressing ~300bp YoY, Q2 swung to a -$8.85M net loss, and the stock has lost 41.75% YTD with relative strength of -53.68. The bull case rests on valuation and forward expectations: 7.65x PS and 3.19x EV/Sales are near historic lows, FCF is a healthy $244.4M TTM, the balance sheet holds $833.4M net cash, and 21 analysts average a $26.57 target (+55.6%). The single most important tension is whether the 16.2x forward PE on $1.68 consensus EPS is achievable — that requires gross margin to stabilize and SBC to normalize, and if Q3 shows margin recovery the de-rating reverses, but if margins keep sliding the 'cheap' multiple is a value trap.
Bullish
- Analyst consensus sees 55.6% upside: All 21 covering analysts carry a consensus 'strong_buy' rating (mean 1.35) with an average target of $26.57 versus the $17.08 price, implying +55.6% upside. Even the lowest target of $19.00 sits 11.2% above the current price, meaning no analyst models further downside from here.
- Valuation compressed to historic lows: PS has collapsed from 32.64x in Q2 2025 to 7.65x today, and EV/Sales is just 3.19x once the $833.4M cash pile is netted against the $9.45B market cap. A forward PE of 16.20x on consensus EPS of $1.68 is far below the 25-40x typical of 26%-growth SaaS names.
- Revenue growth still running at 26.4%: Q2 2026 revenue of $370.58M grew 26.43% YoY and rose sequentially from $358.01M in Q1 and $350.20M in Q4 2025, showing consistent 2-3.5% quarterly compounding. Full-year consensus of ~$2.90B implies mid-20s growth remains intact despite the share price collapse.
- Fortress balance sheet with real cash generation: Debt-to-equity is only 0.10, the current ratio is 4.27, and the company holds $833.4M in cash. Free cash flow is strongly positive at $244.4M TTM (Q2 FCF of $69.27M, ~18.7% margin), so the GAAP loss is an accounting artifact of $51.35M quarterly SBC rather than a cash burn problem.
Bearish
- Gross margin compressing ~300bp YoY: Gross margin fell to 72.62% in Q2 2026 from 75.11% in Q1 and 75.70% in Q2 2025, a roughly 300bp YoY decline. This likely reflects mix shift toward lower-margin SMS and rising AI/infrastructure compute costs, and it undermines the operating-leverage story the 16.2x forward PE depends on.
- Swing back to GAAP net loss: Q2 2026 posted a net loss of -$8.85M (net margin -2.39%) after Q1's +$9.04M profit, with operating income of -$14.96M (-4.04% margin). Trailing net margin of -2.57% and operating margin of -5.49% confirm the company is only marginally profitable and highly volatile quarter to quarter.
- Brutal relative underperformance and downtrend: The stock is down 41.75% YTD and 28.11% over one year versus the S&P 500's +11.93% and +15.53%, producing relative strength of -53.68 YTD. It sits at just 21.9% of its 52-week range ($12.53-$33.355) with a -64.2% max drawdown, and the most recent session fell 5.58%.
- PEG of 8.36 shows growth is not cheap: Despite the optically low forward PE, the PEG ratio of 8.36 signals investors are paying heavily for each unit of earnings growth. The gap between the negative trailing PE (-295.2x) and 16.2x forward PE means profitability is entirely a forward promise, not a demonstrated fact.
KVYO Technical Analysis
Klaviyo is in a sustained, multi-quarter downtrend that has only recently begun to stabilize. The stock is down 28.11% over the trailing year and a striking 41.75% year-to-date, massively underperforming the S&P 500's +15.53% one-year and +11.93% YTD returns, producing a relative strength of -43.64 over one year and -53.68 YTD. At $17.08, the stock sits at roughly 21.9% of its 52-week range (low $12.53, high $33.355) — a positioning that reflects a deeply de-rated, falling-knife profile rather than momentum, though the fact that it is well off the low suggests the worst of the selling may be behind it. The maximum drawdown of -64.2% underscores how severe the repricing has been from the highs.
Short-term momentum is diverging constructively from the longer-term downtrend. The stock is up 5.24% over the past month versus a +1.22% SPY gain, yielding a positive relative strength of +4.02 over one month — the only timeframe where Klaviyo is outperforming the market. However, the 3-month change of -3.34% and 6-month change of -8.52% remain negative, and the 3-month relative strength of -6.03 confirms the one-month bounce is a nascent stabilization rather than an established reversal. The most recent session was sharply negative (-5.58% on the day, from $18.09 to $17.08), suggesting the bounce is encountering resistance; the elevated short ratio of 3.06 days-to-cover indicates meaningful bearish positioning that could fuel squeezes on positive catalysts but also reflects persistent skepticism.
Key technical levels are well defined. Support sits at the 52-week low of $12.53 — a breakdown below that level would signal a fresh leg lower and likely trigger momentum-driven selling, while the $14.00–$15.00 zone (touched repeatedly in June and September) represents intermediate support. Resistance is anchored at the 52-week high of $33.355, with nearer-term resistance around the $20.00–$20.60 area where the stock failed in late August and early September. The beta of 0.671 is notable: despite the brutal drawdown, Klaviyo has historically been less volatile than the market on a beta basis, meaning the decline has been driven by idiosyncratic de-rating rather than broad market beta — a distinction that matters for position sizing, as the stock's risk is company-specific and event-driven (earnings, guidance) rather than macro-correlated.
Beta
0.67
0.67x market volatility
Max Drawdown
-64.2%
Largest decline past year
52-Week Range
$13-$33
Price range past year
Annual Return
-22.9%
Cumulative gain past year
| Period | KVYO Return | S&P 500 |
|---|---|---|
| 1m | +27.6% | -0.1% |
| 3m | +28.8% | +4.7% |
| 6m | +3.8% | +8.3% |
| 1y | -22.9% | +15.2% |
| ytd | -31.1% | +13.4% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
KVYO Fundamental Analysis
Klaviyo's revenue trajectory remains healthy in absolute terms but is decelerating. Q2 2026 revenue came in at $370.58 million, up 26.43% year-over-year from $293.12 million in Q2 2025, and up sequentially from $358.01 million in Q1 2026 and $350.20 million in Q4 2025. The multi-quarter progression ($310.88M in Q3 2025 → $350.20M → $358.01M → $370.58M) shows consistent sequential growth of roughly 2–3.5% per quarter, but the YoY growth rate has moderated from the ~30%+ pace implied by earlier comparisons, and the full-year consensus revenue estimate of ~$2.90 billion implies roughly mid-20s growth. The investment case hinges on whether Klaviyo can sustain 20%+ growth as it scales past a $1.4B+ annualized run-rate, with no segment disclosure available to isolate which product lines (email vs. SMS vs. newer offerings) are driving or dragging growth.
Profitability is thin and volatile. Q2 2026 swung to a net loss of -$8.85 million (net margin -2.39%) from net income of +$9.04 million in Q1 2026, with operating income of -$14.96 million and an operating margin of -4.04%. Gross margin has been compressing: 72.62% in Q2 2026 versus 75.11% in Q1 2026 and 75.70% in Q2 2025, a roughly 300bp YoY decline that likely reflects mix shift toward lower-margin messaging (SMS) and rising infrastructure/AI compute costs. The trailing net margin of -2.57% and operating margin of -5.49% confirm the company is marginally unprofitable on a GAAP basis, and the heavy $51.35 million in quarterly stock-based compensation (versus a -$8.85 million net loss) means GAAP results are being dragged by non-cash comp — a key point of debate for investors assessing true earnings power.
Balance sheet strength is the standout feature of the fundamental picture. Debt-to-equity is just 0.10, the current ratio is a robust 4.27, and the company holds $833.4 million in cash against minimal debt, giving it ample runway to fund growth internally. Free cash flow is strongly positive at $244.4 million TTM, with Q2 2026 FCF of $69.27 million on operating cash flow of $93.88 million and capex of $24.61 million — a healthy ~18.7% FCF margin. However, ROE of -2.65% and ROA of -0.97% reflect the still-negative earnings base, and the company spent $233.57 million on share repurchases in Q2 2026 alone (plus $100 million in Q1), a capital allocation signal that management views the shares as undervalued but that also reduces the cash buffer.
Quarterly Revenue
$370576000.0B
2026-06
Revenue YoY Growth
+26.4%
YoY Comparison
Gross Margin
72.6%
Latest Quarter
Free Cash Flow
$244438000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Open an Account, get $2 TSLA now!
Valuation Analysis: Is KVYO Overvalued?
Because Klaviyo's trailing net income is negative (EPS of -$0.0034, trailing PE of -295.2x), the PE ratio is not meaningful and I am leading with the price-to-sales ratio as the primary metric, supplemented by the forward PE. The stock trades at a PS of 7.65x on trailing revenue and an EV/Sales of just 3.19x — the latter notably low because the ~$833 million cash pile and minimal debt reduce enterprise value relative to the $9.45 billion market cap. The forward PE of 16.20x against consensus EPS of $1.68 is the critical data point: it implies the market expects a dramatic earnings inflection from the current near-zero GAAP EPS, and the enormous gap between the negative trailing PE and the 16.2x forward PE signals that profitability is entirely a forward-looking story dependent on operating leverage and SBC normalization.
On a peer basis, a PS of 7.65x and EV/Sales of 3.19x are modest for a software company growing 26%, and the forward PE of 16.2x is well below typical high-growth SaaS multiples (often 25–40x). The PEG ratio of 8.36, however, is elevated and suggests the growth is not cheap relative to earnings power. The gross margin of 74.67% is solid but below the 80%+ typical of best-in-class SaaS, and the negative net margin (-2.57%) and operating margin (-5.49%) compare unfavorably to profitable SaaS peers. The valuation picture is therefore mixed: optically cheap on EV/Sales and forward PE, but the discount appears justified by margin compression, GAAP unprofitability, and decelerating growth — the market is pricing in execution risk rather than awarding a growth premium.
Historically, Klaviyo's PS ratio has compressed dramatically. It traded at 12.10x in Q2 2026, 16.54x in Q1 2026, 28.10x in Q4 2025, and 32.64x in Q2 2025 — meaning the current 7.65x PS is near the bottom of its own historical band and roughly a quarter of where it traded a year ago. Similarly, the price-to-book ratio has fallen from 8.72x in Q2 2025 to 7.89x currently, and the price-to-free-cash-flow ratio sits at 43.3x versus 197.6x a year ago. This compression reflects both the share price decline and the revenue base growth; at the low end of its historical valuation range, the stock either represents a value opportunity if growth stabilizes, or signals fundamental deterioration the market is correctly anticipating.
PE
-295.2x
Latest Quarter
vs. Historical
Low-End
5-Year PE Range 164x~482x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
-713.2x
Enterprise Value Multiple
Investment Risk Disclosure
Financial and operational risks center on the profitability inflection embedded in the valuation. The forward PE of 16.20x assumes EPS of $1.68 against trailing EPS of -$0.0034, a swing that requires operating leverage the company has not yet demonstrated — Q2 2026 operating income was -$14.96M and gross margin fell to 72.62% from 75.70% a year earlier. Stock-based compensation of $51.35M per quarter dwarfs the -$8.85M net loss, meaning GAAP profitability depends heavily on SBC normalization that may not materialize. Revenue is also concentrated in eCommerce marketing automation with deep Shopify dependence and no segment disclosure, so any slowdown in merchant spending or platform-relationship friction hits the entire top line, which grew 26.43% but is decelerating from prior ~30%+ rates.
Market and competitive risks are dominated by multiple compression and AI disruption. The PS ratio has already fallen from 32.64x to 7.65x in a year, and further de-rating is possible if growth slips below 20% — the PEG of 8.36 shows the market is not yet paying a discount for the growth. The beta of 0.671 is a critical nuance: the -64.2% max drawdown was driven by idiosyncratic, company-specific de-rating rather than market correlation, so diversification offers little protection and earnings events are the real risk vector. Competition from larger marketing suites and AI-native tools threatens to commoditize the core email franchise, and the 3.06 short ratio shows bears are positioned for exactly that outcome.
A worst-case scenario would combine a Q3 gross-margin miss below 72%, guidance cut to sub-20% growth, and continued SBC dilution, triggering analyst downgrades from the current 'strong_buy' consensus and a break below the $14.00-$15.00 intermediate support. That path would take the stock to the 52-week low of $12.53, a -26.6% decline from $17.08, and a break there could extend toward the -64.2% max-drawdown territory seen from the highs. Even the most bearish analyst target of $19.00 implies upside, so the true downside tail is technical rather than fundamental — but with the stock at only 21.9% of its 52-week range, momentum-driven selling below $12.53 remains a live risk.
FAQ
The most severe risk is margin deterioration: gross margin fell to 72.62% in Q2 2026 from 75.70% a year earlier, and if it keeps sliding the 16.20x forward PE on $1.68 EPS becomes unachievable. Second is the profitability swing — Q2 posted a -$8.85M net loss after Q1's +$9.04M profit, with $51.35M of quarterly SBC keeping GAAP earnings negative and volatile. Third is competitive and AI disruption risk, where larger marketing suites or AI-native tools could commoditize the core email franchise, a concern reflected in the 3.06 short ratio. Fourth is momentum and technical risk: the stock is down 41.75% YTD with a -64.2% max drawdown, and a break below the $12.53 52-week low could trigger further selling. Ranked by severity: margin compression, profitability volatility, competitive disruption, then technical breakdown.
The 12-month outlook splits into three scenarios. The base case (50% probability) targets $19-$26, assuming growth holds in the low-to-mid 20s and margins stabilize without fully recovering, with the stock grinding toward the $26.57 analyst average. The bull case (25%) targets $26-$36, requiring gross margin above 74%, positive operating income, and multiple expansion toward the $36.00 high target. The bear case (25%) targets $12.53-$19, driven by a margin miss, sub-20% growth, and a retest of the 52-week low. The base case is most likely because revenue growth of 26.43% is intact and FCF of $244.4M TTM supports the business, but the key assumption is that gross margin stabilizes in the 72-74% band rather than continuing to erode.
On most measures KVYO looks undervalued relative to its own history: PS has fallen from 32.64x in Q2 2025 to 7.65x, price-to-FCF from 197.6x to 43.3x, and price-to-book from 8.72x to 7.89x. EV/Sales of 3.19x is modest for a 26.43%-growth software company, and the forward PE of 16.20x is well below the 25-40x typical of high-growth SaaS peers. However, the PEG ratio of 8.36 and the negative trailing PE of -295.2x show the market is not paying a discount for growth so much as pricing execution risk — gross margin compression and GAAP unprofitability justify part of the de-rating. The market is implying it expects the $1.68 consensus EPS to be roughly achieved; if it is, the stock is undervalued, and if margins keep sliding, the multiple is fair or even rich.
From a risk/reward perspective, KVYO offers an asymmetric setup: the average analyst target of $26.57 implies +55.6% upside, and even the lowest target of $19.00 is 11.2% above the $17.08 price, while the 52-week low of $12.53 caps the realistic downside at roughly -26.6%. The valuation is undemanding at 7.65x PS and 3.19x EV/Sales, backed by $833.4M net cash and $244.4M TTM free cash flow. The catch is that the 16.20x forward PE depends on an EPS inflection to $1.68 that Q2's -$8.85M net loss and 72.62% gross margin do not yet support. It is a good buy for patient investors with a 12-18 month horizon who can tolerate volatility and want to accumulate on weakness; it is not a good buy for those needing near-term GAAP profitability or momentum confirmation.
KVYO is better suited to a long-term hold with a minimum 12-18 month horizon than to short-term trading. The company is still in a growth stage — 26.43% revenue growth on a $1.4B+ annualized run-rate — with a beta of 0.671 that understates its event-driven volatility, since the -64.2% drawdown came from idiosyncratic de-rating rather than market correlation. It pays no dividend (payout ratio 0, yield 0), so returns depend entirely on capital appreciation and the profitability inflection. Earnings visibility is low given the Q1-to-Q2 swing from +$9.04M to -$8.85M net income, making quarter-to-quarter trading risky. A patient investor should allow at least four to six quarters for gross margin and SBC trends to normalize and for the 16.20x forward PE thesis to be tested.
